Maria-Luisa Maccecchini's Net Worth
$10.5 Million
Who is Maria-Luisa Maccecchini?
Maria-Luisa Maccecchini has an estimated net worth of $10.5 Million. This is based on reported shares across multiple companies, which include COMPETITIVE TECHNOLOGIES INC, Annovis Bio, Inc., and Lantern Pharma Inc..
SEC CIK
Maria-Luisa Maccecchini's CIK is 0001315018
Past Insider Trading and Trends
2023 was Maria-Luisa Maccecchini's most active year for acquiring shares with 5 total transactions. Maria-Luisa Maccecchini's most active month to acquire stocks was the month of December. 2020 was Maria-Luisa Maccecchini's most active year for disposing of shares, totalling 2 transactions. Maria-Luisa Maccecchini's most active month to dispose stocks was the month of December. 2021 saw Maria-Luisa Maccecchini paying a total of $496,980.00 for 318,000 shares, this is the most they've acquired in one year. In 2020 Maria-Luisa Maccecchini cashed out on 1,079,165 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
COMPETITIVE TECHNOLOGIES INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.5K |
—
|
—
| 2.5K |
Jan 3 - Jan 4
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jan 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Annovis Bio, Inc. (ANVS) Snapshot price: $10.76
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| +3.87% | 40.97K |
$6.10 | $249,917.00 | 1.1M |
Nov 20
| |||
Form 4
| +3.89% | 41.19K |
$6.07 | $249,999.02 | 1.1M |
Nov 20
| |||
Form 4
| -0.28% | -3.00K |
—
|
—
| 1.06M |
Apr 24
| |||
Form 4
| +1.92% | 20K |
$12.61 | $252,200.00 | 1.06M |
Apr 7
| |||
Form 4
| +5.34% | 52.76K |
$0.14 | $7,385.70 | 1.04M |
Feb 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
| +3.45% | 32.96K |
$0.14 | $4,614.26 | 987.73K |
Jan 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 6
| |||
Form 4
| +1.88% | 18K |
$27.61 | $496,980.00 | 976.77K |
Oct 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 9
| |||
Form 4
| +374.35% | 772.43K |
$6.00 |
—
| 978.77K |
Jan 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Lantern Pharma Inc. (LTRN) Snapshot price: $4.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||